Description
Product details
DERIFENAC 7.5 DERIFENAC 7.5 is a clinically proven formulation of Darifenacin Prolonged Release Tablets IP 7.5 mg, designed to effectively manage symptoms of an overactive bladder (OAB). Overactive bladder is a common condition characterized by frequent urination, urgency, and involuntary leakage (urge incontinence), which can significantly impact daily life and confidence. DERIFENAC 7.5 works by relaxing the bladder muscles, allowing better control over urination and reducing unwanted symptoms. Its prolonged-release technology ensures a steady and sustained effect throughout the day, improving convenience and patient compliance. Composition Overview Each prolonged-release tablet of DERIFENAC 7.5 contains: Darifenacin Hydrobromide (equivalent to Darifenacin 7.5 mg) Darifenacin belongs to a class of medications known as antimuscarinic agents, which specifically target bladder muscle receptors responsible for involuntary contractions. How It Works DERIFENAC 7.5 acts by selectively blocking M3 muscarinic receptors in the bladder. These receptors play a key role in controlling bladder muscle contractions. By inhibiting these receptors: The bladder muscle relaxes Storage capacity of the bladder increases Sudden urges to urinate are reduced The prolonged-release formulation ensures that the medication is released slowly over time, providing consistent symptom control with once-daily dosing. Uses of DERIFENAC 7.5 1. Overactive Bladder (OAB) The primary use of DERIFENAC 7.5 is to treat symptoms of OAB, including: Frequent urination Urgency (sudden need to urinate) Urge incontinence (leakage of urine) 2. Urinary Control Improvement Helps individuals regain better control over bladder function, reducing interruptions in daily activities and sleep. 3. Quality of Life Enhancement By minimizing embarrassing symptoms, it improves confidence and overall quality of life. Key Benefits ✔ Long-Lasting Relief The prolonged-release formula ensures 24-hour symptom control with a single daily dose. ✔ Reduced Urinary Frequency Helps decrease the number of times a person needs to urinate during the day and night. ✔ Better Bladder Control Improves the ability to hold urine, reducing accidental leakage. ✔ Selective Action Targets specific bladder receptors, minimizing unwanted systemic effects compared to non-selective drugs. ✔ Improved Sleep Quality Reduces nighttime urination (nocturia), allowing uninterrupted sleep. ✔ Convenient Dosage Once-daily dosing improves adherence and ease of use. Directions for Use Take DERIFENAC 7.5 exactly as prescribed by your healthcare professional. Swallow the tablet whole with water; do not crush or chew. It can be taken with or without food. Take it at the same time each day for best results. Note: Do not alter the dose without consulting your doctor. Possible Side Effects Like all medications, DERIFENAC 7.5 may cause some side effects, although not everyone experiences them. Common Side Effects Dry mouth Constipation Blurred vision Indigestion Headache Less Common Side Effects Urinary retention Dizziness Fatigue Rare Side Effects Severe allergic reactions Difficulty in urination Most side effects are mild and tend to improve as the body adjusts to the medication. Precautions Use with caution in patients with liver impairment. Not recommended for individuals with urinary retention or gastric retention. Inform your doctor if you have glaucoma or gastrointestinal disorders. Avoid alcohol consumption as it may increase drowsiness or side effects. Pregnant or breastfeeding women should use this medication only if prescribed. Storage Instructions Store in a cool and dry place below 25°C Protect from moisture and direct sunlight Keep out of reach of children Conclusion DERIFENAC 7.5 (Darifenacin Prolonged Release Tablets IP 7.5 mg) is a reliable and effective solution for managing overactive bladder symptoms. With its targeted mechanism and prolonged-release technology, it offers consistent, all-day relief from urinary urgency, frequency, and incontinence.
